Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Oxford Bioscience Partners
AddedFeb 13, 2024
UpdatedJul 16, 2026
Oxford Bioscience Partners

Oxford Bioscience Partners

Operating

Oxford Bioscience Partners: A global venture capital firm investing in life sciences, tech, energy, and healthcare.

Location
Boston, MA, US
Founded
1992
Firm
Compare
Portfolio
Employees
Website

Oxford Bioscience Partners is a global venture capital firm that focuses on investing in the life sciences, technology, energy, and healthcare sectors. The firm typically participates in various stages of funding, including Series A, B, C, D, and beyond, with a notable presence in Series B rounds. Their investments span a wide range of companies worldwide, reflecting their broad industry focus and commitment to fostering innovation across multiple sectors.

Notable portfolio companies include Accelerated Technologies, Adastra Pharmaceuticals, BrainCells, Cambrios Technologies, and CardioFocus. Key decision-makers at Oxford Bioscience Partners bring extensive experience and industry connections to the table, enhancing the firm's ability to support its portfolio companies. The firm prides itself on offering unique value-add services, such as strategic guidance and leveraging their global network to help startups scale effectively.

Oxford Bioscience Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments45
Current Portfolio Count14
Total Portfolio Exits6

Top Investment Stages

Series A11 (28.9%)
Series B11 (28.9%)
Series C7 (18.4%)
Series Unknown5 (13.2%)
Series D4 (10.5%)

Stage Mix

Series A 29%Series B 29%Series C 18%Series Unknown 13%Series D 11%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Yolia Health logo

Yolia Health

CardioFocus logo

CardioFocus

Glori Energy logo

Glori Energy

Adastra Pharmaceuticals logo

Adastra Pharmaceuticals

Molecular Biometrics logo

Molecular Biometrics

Cambrios Technologies logo

Cambrios Technologies

Elixir Pharmaceuticals logo

Elixir Pharmaceuticals

Zettacore logo

Zettacore

BrainCells logo

BrainCells

Select Laboratory Partners logo

Select Laboratory Partners

Hydrocision logo

Hydrocision

Ensemble Discovery logo

Ensemble Discovery

Courtagen Life Sciences logo

Courtagen Life Sciences

Xencor logo

Xencor

Enanta Pharmaceuticals logo

Enanta Pharmaceuticals

Intrapace logo

Intrapace

Accelerated Technologies logo

Accelerated Technologies

Cyberkinetics logo

Cyberkinetics

Dynogen Pharmaceuticals logo

Dynogen Pharmaceuticals

MicroMed Technology logo

MicroMed Technology

Scion Pharmaceuticals logo

Scion Pharmaceuticals

Variagenics logo

Variagenics

Exelixis logo

Exelixis

Message Pharmaceuticals logo

Message Pharmaceuticals

Oxford Bioscience Partners - Similar Investment Firms

Oxford Sciences Innovation logo

Oxford Sciences Innovation

oxfordsciences.com

Oxantium Ventures logo

Oxantium Ventures

oxantium.com

Oxford Capital Partners logo

Oxford Capital Partners

oxcp.com

Bioventures Investors logo

Bioventures Investors

Bios Partners logo

Bios Partners

biospartners.com

OMX Ventures logo

OMX Ventures

omx.vc

Blue Ox Healthcare Partners logo

Blue Ox Healthcare Partners

blueoxhcp.com

Biospring Partners logo

Biospring Partners

biospring.com

Oxford Technology Management logo

Oxford Technology Management

Oxford Finance logo

Oxford Finance

oxfordfinance.com

LifeSci Venture Partners logo

LifeSci Venture Partners

lifesciventure.com

Oak Investment Partners logo

Oak Investment Partners

oakvc.com

Oxeon Partners logo

Oxeon Partners

oxeon.com

venBio Partners logo

venBio Partners

venbio.com

Osage Venture Partners logo

Osage Venture Partners

osagepartners.com

Oxford Bioscience Partners - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end